Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.99

-0.1%

11:42 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biotech Jim who wrote (8361)	5/15/2003 9:25:19 AM
From: Biomaven	Read Replies (1) of 52153

Thanks, Jim. there is room for IV formulations for acute care drugs IMO I was thinking along the lines of recent cancer studies showing a bunch of genes that are over-expressed. I could conceive of a cocktail of siRNA's tailored to inhibit the offending genes. Perhaps I am being overly simplistic. I should look at Isis again - thanks for the suggestion. Gotta love this market for the biotechs, eh? What a month! Yes, indeed. I feel like I have been living a charmed life in the market of late. Not only have my biotechs been doing great, but so have my non-biotech shorts and my treasuries and foreign bond fund. I had my best day in a long time yesterday, and that on a day when the overall market was down. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next